期刊文献+

慢病毒载体系统介导hUC-MSC绿色荧光蛋白和荧光素酶共表达技术体系的建立 被引量:3

Establishment of technology of co-expression of green fluorescent protein and luciferase in human umbilical cord mesenchymal stem cell via lentiviral expression system
原文传递
导出
摘要 目的建立慢病毒载体系统介导的人脐带间充质干细胞(hUC-MSC)绿色荧光蛋白(GFP)和荧光素酶共表达技术体系。方法 GFP和荧光素酶共表达慢病毒载体与相应包装质粒psPAX2和pMD2.G经聚乙烯亚胺介导共转染HEK293T细胞以包装病毒;病毒感染P4代hUC-MSC 12 h后,再行嘌呤霉素筛选24 h,普通光学显微镜观察细胞形态,荧光显微镜下观察GFP的表达情况,IVIS Kinetic成像系统拍照以观察和记录慢病毒感染后hUC-MSC荧光素酶的表达情况;MTS法行细胞生长曲线作图,同时,普通和实时定量RTPCR法检测细胞周期调控相关蛋白Cyclin D1、Cyclin E1和p21WAF1/CIP1的表达。采用方差分析和t检验进行统计学分析。结果慢病毒感染并不会造成体外培养hUC-MSC形态的明显改变,而荧光显微镜和IVIS Kinetic成像系统的观察结果则分别证实,GFP和荧光素酶经慢病毒载体系统的介导可在hUC-MSC中成功地共表达。此外,细胞生长曲线作图结果表明,对照和GFP及荧光素酶共表达慢病毒感染后hUC-MSC的生长增殖速率相仿(P>0.01);实时定量RT-PCR法检测结果则显示,与对照慢病毒感染相比,GFP和荧光素酶共表达慢病毒感染后其细胞周期调控相关蛋白Cyclin D1、Cyclin E1和p21WAF1/CIP1mRNA表达水平分别是对照组的1.11倍(P=0.130)、0.54倍(P=0.000)和0.78倍(P=0.005),表明外源GFP和荧光素酶共表达对体外培养的hUC-MSC生长增殖等表型无显著影响。结论慢病毒载体系统可有效介导外源基因在hUC-MSC中的表达;同时,GFP和荧光素酶在hUC-MSC中的共表达也将极大地方便其体内转归的示踪。 Objective To establish technology of co-expression of green fluorescent protein(GFP) and luciferase in human umbilical cord mesenchymal stem cell(hUC-MSC) via lentiviral system. Methods The HEK293T cells were co-transfected with lentiviral coexpressing vector of GFP and luciferase and two package plasmids(psPAX2 and pMD2.G) to yield lentivirus. Human umbilical cord mesenchymal stem cells(P4) were infected with harvested lentivirus for 12 hrs and then subjected for selection with Puromycin for additional 24 hrs.Cell morphology was examined under microscope. The expression of GFP and luciferase was detected by fluorescent microscopy and IVIS Kinetic image system, respectively. MTS assay was applied to survey the proliferation of infected cells. The regular and real-time RT-PCR was carried out to analyze the mRNA expression of cell cycle regulators Cyclin D1, Cyclin E1 and p21WAF1/CIP1. Analysis of variance and t test was used for statistical analysis. Results Lentiviral infection resulted in no significant morphological change of hUC-MSC cultured in vitro. The coexpression of GFP and luciferase in hUC-MSC via lentiviral expression system was visualized by microscopy and IVIS Kinetic image system. The proliferation rate of hUCMSC infected with GFP and luciferase co-expressing lentiviruses was the same as that of control lentiviruses infected hUC-MSC as indicated by MTS assay results(P > 0.01). In addition, the realtime RT-PCR results showed that the lentiviral system mediated co-expression of exogenous GFP and luciferase in hUC-MSC wouldn’t cause any significant change of expression of cell cycle regulators Cyclin D1(1.11 fold, P = 0.130), Cyclin E1(0.54 fold, P = 0.000) and p21WAF1/CIP1(0.78 fold, P = 0.005) as compared with that of control viral infection. Conclusions The lentiviral expression system can be used to mediate expression of exogenous genes in hUCMSC.The introduced co-expression of GFP and luciferase in hUC-MSC will facilitate the in vivo tracing after infusion.
出处 《中华细胞与干细胞杂志(电子版)》 2013年第3期6-11,共6页 Chinese Journal of Cell and Stem Cell(Electronic Edition)
基金 国家自然科学基金面上项目(81272922) 福建省科技创新平台建设项目(2010Y2006)
关键词 慢病毒 脐带间充质干细胞 绿色荧光蛋白 荧光素酶 外源 基因共表达 Lentivirus Umbilical cord mesenchymal stem cells (UC-MSCs) Green fluorescent protein (GFP) Luciferase Co-expression of exogenous genes
  • 相关文献

参考文献14

  • 1Baksh D,Yao R,Tuan RS.Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow[J].Stem Cells,2007,25(6):1384-1392.
  • 2Uccelli A,Moretta L,Pistoia V.Mesenchymal stem cells in health and disease[J].Nat Rev Immunol,2008,8(9):726-736.
  • 3Micci MA,Learish RD,Li H.Neural stem cells express RET,produce nitric oxide,and survive transplantation in the gastrointestinal tract[J].Gastroenterology,2001,21(4):757-766.
  • 4刘述,谢瑶,陈系古,姚志彬.小鼠胚胎干细胞植入大鼠脑内分化的研究(英文)[J].中国临床康复,2003,7(16):2258-2259. 被引量:3
  • 5Mcdonald JW,Liu XZ,Qu Y,et al.Transplanted embryonic stem cells survive,differentiate and promote recovery in injured rat spinal cord[J].Nature medicine,1999,5(12):1410-1412.
  • 6杨顺良,谭建明.肾脏疾病的干细胞治疗[J].中华细胞与干细胞杂志(电子版),2011,1(2):1-8. 被引量:1
  • 7Nauta AJ,Fibbe WE.Immunomodulatory properties of mesenchymal stromal cells[J].Blood,2007,110(10):3499-3506.
  • 8Uccelli A,Pistoia V,Moretta L.Mesenchymal stem cells:a new strategy for immunosuppression?[J].Trends Immunol,2007,28(5):219-226.
  • 9Uccelli A,Moretta L,Pistoia V.Mesenchymal stem cells in health and disease[J].Nat Rev Immunol,2008,8(9): 726-736.
  • 10Tan J,Wu W,Xu X,et al.Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants:a randomized controlled trial[J].JAMA,2012,307(11):1169-1177.

二级参考文献109

  • 1葛殿华,马红梅,周学武,呼晓,冯丽艳,雷娟,杨淑梅,毛慧玲,宁彬.脐带血血清培养体系扩增脐带间充质干细胞及其生物学特征的实验研究[J].黑龙江医药,2009,22(6):799-801. 被引量:3
  • 2袁源,王媛丽,杨树源,韩忠朝,张晓辉.人脐带间质干细胞分离纯化及基本生物学特性研究[J].青岛大学医学院学报,2006,42(2):120-122. 被引量:16
  • 3Langer R.Tissue engineering.Science.1993;260:920-926.
  • 4Connolly JF.Injectable bone marrow preparations to stimulateosteogenic repair.Clin Orthop Relat Res.1995;313:8-18.
  • 5Mendes SC,Tibbe JM,Veenhof M,et al.Bone tissue-engineered implants using human bone marrow stromal cells:effect of culture conditions and donor age.Tissue Eng.2002;8(6):911-920.
  • 6Romanov YA,Svintsitskaya VA,Smirnov VN.Searching for alternativesources of postnatal human mesenchymal stem cells:candidate MSC-like cells from umbilical cord.Stem Cells.2003;21(1):105-108.
  • 7Baksh D,Yao R,Tuan RS.Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow.Stem Cells.2007; 25(6):1384-1392.
  • 8Covas DT,Siufi JL,Silva AR,et al.Isolation and culture of Umbilical vein mesenchymal stem cells.Braz J Med Biol Res.2003;36:1179-1183.
  • 9Saugaser R,Lickorish D,Baksh D,et al.Human umbilical cord perivascular cells:a sourse of mesenchymal progenitors.Stem Cells.2005; 23(2):220-229.
  • 10Karahuseyinoglu S,Cinar O,Kilic E,et al.Biology of stem cells in human umbilical cord stroma:in situ and in vitro surveys.Stem Cells.2007;25(2):319-331.

共引文献22

同被引文献32

  • 1王卓娅,傅强,刘彩云,梁高卫,吴培诚.雄激素受体激动剂与拮抗剂高通量筛选细胞模型的构建[J].基因组学与应用生物学,2015,34(3):472-475. 被引量:3
  • 2Wang J, Liao L, Wang S, et al. Cell therapy with autologous mesenchymal stem cells--how the disease process impacts clinical considerations[J]. Cytotherapy, 2013, 15(8):893-904.
  • 3Reagan MR, Kaplan DL. Concise review. Mesenchymal stem cell tumor homing: detection methods in disease model systems[J]. Stem Cells, 2011, 29(6):920-927.
  • 4Goldstein RH, Reagan MR, Anderson K, et al. Human bone marrow-derived MSCs can home to orthotopic breast cancer tumors and promote bone metastasis[J]. Cancer Res, 2010, 70(24): 10044-10050.
  • 5Studeny M, Marini FC, Dembinski JL, et ah Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents[J]. J Natl Cancer Inst, 2004, 96(21 ): 1593-1603.
  • 6Kanehira M, Xin H, Hoshino K, et ah Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells[J]. Cancer Gene Ther, 2007, 14(11): 894-903.
  • 7Kucerova L, Altanerova V, Matuskova M, et al. Adipose tissue-derived human mesenchymal stern cells mediated prodrug cancer gene therapy[J]. Cancer Res, 2007, 67(13): 6304-6313.
  • 8Xin H, Kanehira M, Mizuguchi H, et ah Targeted delivery of CX3CL1 to multiple lung tumors by mesenchymal stem cells[J]. Stem Cells, 2007, 25(7): 1618-1626.
  • 9Ashkenazi A. Targeting the extrinsic apoptosis pathway in cancer[J]. Cytokine Growth Factor Rev, 2008, 19(3-4):325-331.
  • 10Johnstone RW, Frew AJ, Smyth MJ. The TRAIL apoptotic pathway in cancer onset, progression and therapy[J]. Nat Rev Cancer, 2008, 8(10):782-798.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部